Author:
Ambrogio Francesca,Rubino Luca,Laface Carmelo,Cazzato Gerardo,Foti Caterina
Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Pembrolizumab;Flynn JP,2024
2. Adverse cutaneous toxicities by PD-1/PD-L1 immune checkpoint inhibitors: pathogenesis, treatment, and surveillance;Bhardwaj M;Cutan Ocul Toxicol,2022
3. Rupioid psoriasis induced by pembrolizumab;Marti-Marti I;Indian J Dermatol Venereol Leprol,2020
4. Rupioid psoriasis and other skin diseases with rupioid manifestations;Chung HJ;Cutis,2014
5. Rupioid psoriasis;Ip KH;JAMA Dermatol,2021